Combined drug significantly reverses memory loss in Alzheimer’s mice
Independent - 01-Jan-2018Treatment combined diabetes drugs GLP-1, GIP and glucagon. Type 2 diabetes is a known risk facto...
Join the club for FREE to access the whole archive and other member benefits.
Professor of Neuroscience at the Henan University of Chinese Medicine and CSO of Kariya Pharmaceuticals
Dr. Holscher is a professor of neuroscience at the Henan University of Chinese Medicine, China. His group is pioneering the development of novel drug treatments for Alzheimer’s and Parkinson’s Disease, with specific focus on researching the interaction between diabetes and neurodegeneration, leading to the discovery of the neuroprotective properties of incretin analogues. A key opinion leader authoring over 180 scientific publications and two books, his research has been funded by the Alzheimer’s Society, Alzheimer’s Research UK, Cure Parkinson’s Trust, Alzheimer’s Drug Discovery Foundation, and The Wellcome Trust. Dr. Holscher is a recent recipient of a Lundbeckfonden visiting professorship to Copenhagen University and is also a visiting professor at Shanxi Medical University in Taiyuan, China, where extensive research in animal models of neurodegeneration is ongoing.
Visit website: http://www.christian-holscher.info/index.html
See also: Kariya Pharmaceuticals - Company that develops disease-modifying agents to treat neurodegenerative diseases
Details last updated 16-Apr-2020
Treatment combined diabetes drugs GLP-1, GIP and glucagon. Type 2 diabetes is a known risk facto...